President Biden, in July 2021, issued an Executive Order (“E.O.”) observing that “too often, patent and other laws have been misused to inhibit or delay — for years and even decades — competition from generic drugs and...more
3/7/2023
/ Abbreviated New Drug Application (ANDA) ,
Biden Administration ,
Executive Orders ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
FOIA ,
Food and Drug Administration (FDA) ,
Patent Applications ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
PHRMA ,
Public Disclosure ,
Trade Secrets ,
USPTO